Citigroup Inc Catalent, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Citigroup Inc holds 204,923 shares of CTLT stock, worth $13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

204,923

Previous 162,406 26.18%

Holding current value

$13 Million

Previous $9.13 Million 35.92%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $2.39 Million - $2.59 Million	42,517 Added 26.18%	204,923 $12.4 Million
Q2 2024 Aug 12, 2024	SELL	$53.58 - $57.02 $34.2 Million - $36.4 Million	-637,738 Reduced 79.7%	162,406 $9.13 Million
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $10.8 Million - $15.2 Million	-254,302 Reduced 24.12%	800,144 $45.2 Million
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $19 Million - $27.5 Million	589,478 Added 126.78%	1,054,446 $47.4 Million
Q3 2023 Nov 09, 2023	SELL	$44.2 - $50.2 $4.45 Million - $5.05 Million	-100,588 Reduced 17.79%	464,968 $21.2 Million
Q2 2023 Aug 10, 2023	BUY	$31.86 - $67.26 $15.2 Million - $32.2 Million	478,409 Added 548.97%	565,556 $24.5 Million
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $257,417 - $420,682	5,665 Added 6.95%	87,147 $5.73 Million
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $536,455 - $1.05 Million	-12,961 Reduced 13.72%	81,482 $3.67 Million
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $3.64 Million - $5.69 Million	50,299 Added 113.94%	94,443 $6.84 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $1.73 Million - $2.27 Million	-19,878 Reduced 31.05%	44,144 $4.74 Million
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $4.85 Million - $6.4 Million	-51,443 Reduced 44.55%	64,022 $7.1 Million
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $4.79 Million - $5.57 Million	40,043 Added 53.09%	115,465 $14.8 Million
Q3 2021 Nov 10, 2021	BUY	$109.17 - $142.35 $8.23 Million - $10.7 Million	75,422 New	75,422 $10 Million

Others Institutions Holding CTLT

# of Institutions

509

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account